Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Acute Myeloid Leukemia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... therapeutics. Synopsis In 2022, there will be more than 156,000 diagnosed prevalent cases of acute myeloid leukemia across 16 pharmaceutical markets. There are 10 leading marketed drugs for the treatment of acute myeloid leukemia, Bristol ... Read More
-
Synovial Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape. Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, ... Read More
-
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteosarcoma (Oncology) pipeline landscape. Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone ... Read More
-
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... In Development, 2022, provides an overview of the Hodgkin Lymphoma (Oncology) pipeline landscape. Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes. Symptoms include painless swelling of the lymph nodes in ... Read More
-
Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022 - 2028
... Cancer Gene Therapy Market would witness market growth of 20.3% CAGR during the forecast period (2022-2028). Favorable government therapeutic laws would further enhance numerous prospects, resulting in the expansion of the cancer gene therapy market ... Read More
-
Rectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are ... Read More
-
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
... size is expected to reach over USD 22.87 billion by 2030, registering a CAGR of 16.4% during the forecast period, according to a new report by Grand View Research Inc. The presence of strong pipeline ... Read More
-
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Nasopharyngeal Cancer (Oncology) pipeline landscape. Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is ... Read More
-
Biomarkers Market - Global Outlook & Forecast 2022-2027
... tools to predict prognosis and response to therapy in cancer patients. Furthermore, it allows to improve understanding of mechanisms of action and resistance to treatment. The global biomarkers market is expected to grow at a ... Read More
-
APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)), Technology (Traditional, Specialty), Application (Cancer, Diabetes), & End User (Hospital, Home Care) - Fore cast to 2027
... is expected to reach USD 5.7 billion by 2027 from an estimated USD 3.7 billion in 2022, at a CAGR of 9.1%. The growth of this market is majorly driven by the increasing incidence of ... Read More
-
Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Cancer), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe ... Read More
-
Global Synthetic Stem Cells Market Size study, by Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorder), By End-Use (Hospitals And Surgical Centers, Academic Institutes, Research Laboratories, Pharmaceutical And Biotechnology Companies, Others) and Regional Forecasts 2022-2028
... Forecasts 2022-2028 Global Synthetic Stem Cells Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... and Forecast, 2021-2031 Japan Direct-to-Consumer Laboratory Testing Market – Scope of Report TMR’s report on the direct-to-consumer laboratory testing market in Japan studies the past as well as the current growth trends and opportunities to ... Read More
-
Global Long-acting Monoclonal Antibodies Market Size Study, By Source Type (Murine, Chimeric, Humanized, Human) By Indication (Cancer, Autoimmune Disease, Inflammatory Disease, Infectious Disease, Others) By End-User (Hospital Pharmacies, Drug Store, Retail Pharmacies, E-Commerce) and regional forecasts 2022-2028
... forecasts 2022-2028 Global Long-acting Monoclonal Antibodies Market is valued approximately USD xx Billion in 2021 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2022-2028. ... Read More
-
Global Molecular Cytogenetics Market Size study, by Product (Kits & Reagents, Instruments, Consumables, Software & Services), by Application (Genetic Disorders, Cancer, Personalized Medicine, Other Applications), by End-use (Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-users) and Regional Forecasts 2022-2028
... and Biotechnology Companies, Other End-users) and Regional Forecasts 2022-2028 Global Molecular Cytogenetics Market is valued at approximately USD 2.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
2022 Global Forecast for Cancer Diagnostics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Lung Cancer Surgery (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Intraoperative Radiation Therapy (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... expected to reach USD 5,656.58 million by 2027, registering a CAGR of 7.43% from 2022 to 2027. The outbreak of COVID-19 significantly reduced hospital and healthcare services, impacting the pancreatic cancer therapeutics and diagnostics market. ... Read More
-
Global Cancer Immunotherapy Market Size study, By Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), By Application (Lung Cancer, Breast Cancer, Head and Neck Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Others), By End User (Hospitals, Clinics & Others), and Regional Forecasts 2022-2028
... Clinics & Others), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Market is valued approximately USD 119.31 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the ... Read More
-
Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028
... Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 158,442 diagnosed prevalent cases of pancreatic cancer across 16 pharmaceutical markets. There are five leading marketed drugs for the treatment of pancreatic cancer, AstraZeneca is a key player ... Read More
-
Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others)
... (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others) The metastatic cancer ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The South & Central America monoclonal antibodies market is expected to reach US$ 10,847.3 million by ... Read More
Research Assistance
